Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRE-GCA Pilot: Aspirin for Ischemic Events in Giant Cell Arteritis
NCT07908082Phase 3Not yet recruiting
- Start
- Oct 2027
- Primary completion
- Oct 2030
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in giant cell arteritis (GCA). Planned start Oct 2027; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
giant cell arteritis (GCA)
Beyond the preview
Go deeper on NCT07908082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07908082.